Monographs on the medicinal uses of plant drugs. Exeter, UK: European Scientific Co-op Phytother, 1997.
Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.
Tyler VE. Herbs of Choice. Binghamton, NY: Pharmaceutical Products Press, 1994.
Newall CA, Anderson LA, Philpson JD. Herbal Medicine: A Guide for Healthcare Professionals. London, UK: The Pharmaceutical Press, 1996.
The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.
Leung AY, Foster S. Encyclopedia of Common Natural Ingredients Used in Food, Drugs and Cosmetics. 2nd ed. New York, NY: John Wiley & Sons, 1996.
McGuffin M, Hobbs C, Upton R, Goldberg A, eds. American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press, LLC 1997.
Robbers JE, Speedie MK, Tyler VE. Pharmacognosy and Pharmacobiotechnology. Baltimore, MD: Williams & Wilkins, 1996.
McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.
Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
Covington TR, et al. Handbook of Nonprescription Drugs. 11th ed. Washington, DC: American Pharmaceutical Association, 1996.
Burnham TH, ed. Drug Facts and Comparisons, Updated Monthly. Facts and Comparisons, St. Louis, MO.
Ipecac for the home treatment of poisonings. Pharmacist's Letter/Prescriber's Letter 2003;19(12):191201.
Anon. Position paper: Ipecac syrup. J Toxicol Clin Toxicol 2004;42:133-43.
Wax, P. M., Cobaugh, D. J., and Lawrence, R. A. Should home ipecac-induced emesis be routinely recommended in the management of toxic berry ingestions? Vet.Hum.Toxicol. 1999;41(6):394-397.
Scharman, E. J., Hutzler, J. M., Rosencrance, J. G., and Tracy, T. S. Single dose pharmacokinetics of syrup of ipecac. Ther.Drug Monit. 2000;22(5):566-573.
Yamashita, M., Yamashita, M., and Azuma, J. Urinary excretion of ipecac alkaloids in human volunteers. Vet.Hum.Toxicol. 2002;44(5):257-259.
Bond, G. R. Home syrup of ipecac use does not reduce emergency department use or improve outcome. Pediatrics 2003;112(5):1061-1064.
Meadows-Oliver, M. Syrup of ipecac: new guidelines from the AAP. J.Pediatr.Health Care 2004;18(2):109-110.
Silber, T. J. Ipecac syrup abuse, morbidity, and mortality: isn't it time to repeal its over-the-counter status? J Adolesc.Health 2005;37(3):256-260.
Rashid, N. Medically unexplained myopathy due to ipecac abuse. Psychosomatics 2006;47(2):167-169.
Kornberg, A. E. and Dolgin, J. Pediatric ingestions: charcoal alone versus ipecac and charcoal. Ann.Emerg.Med 1991;20(6):648-651.
Lewis, R. K. and Paloucek, F. P. Assessment and treatment of acetaminophen overdose. Clin Pharm 1991;10(10):765-774.
Kendrick, D., Smith, S., Sutton, A., Watson, M., Coupland, C., Mulvaney, C., and Mason-Jones, A. Effect of education and safety equipment on poisoning-prevention practices and poisoning: systematic review, meta-analysis and meta-regression. Arch Dis.Child 2008;93(7):599-608.
Lee, M. R. Ipecacuanha: the South American vomiting root. J R.Coll.Physicians Edinb. 2008;38(4):355-360.
Stiell, I. G. Activated charcoal alone versus activated charcoal & ipecac. Ann.Emerg.Med. 1990;19(10):1202-1204.
Merigian, K. S., Woodard, M., Hedges, J. R., Roberts, J. R., Stuebing, R., and Rashkin, M. C. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg.Med 1990;8(6):479-483.
Albertson, T. E., Derlet, R. W., Foulke, G. E., Minguillon, M. C., and Tharratt, S. R. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Ann.Emerg.Med 1989;18(1):56-59.
Tandberg, D. and Murphy, L. C. The knee-chest position does not improve the efficacy of ipecac-induced emesis. Am.J.Emerg.Med. 1989;7(3):267-270.
Day, L., Kelly, C., Reed, G., Andersen, J. M., and Keljo, J. M. Fatal cardiomyopathy: suspected child abuse by chronic ipecac administration. Vet.Hum.Toxicol. 1989;31(3):255-257.
McNamara, R. M., Aaron, C. K., Gemborys, M., and Davidheiser, S. Efficacy of charcoal cathartic versus ipecac in reducing serum acetaminophen in a simulated overdose. Ann.Emerg.Med 1989;18(9):934-938.
Kuntzer, T., Bogousslavsky, J., Deruaz, J. P., Janzer, R., and Regli, F. Reversible emetine-induced myopathy with ECG abnormalities: a toxic myopathy. J Neurol. 1989;236(4):246-248.
Mateer, J. E., Farrell, B. J., Chou, S. S., and Gutmann, L. Reversible ipecac myopathy. Arch.Neurol. 1985;42(2):188-190.
Moldawsky, R. J. Myopathy and ipecac abuse in a bulimic patient. Psychosomatics 1985;26(5):448-449.
Kulig, K., Bar-Or, D., Cantrill, S. V., Rosen, P., and Rumack, B. H. Management of acutely poisoned patients without gastric emptying. Ann.Emerg.Med 1985;14(6):562-567.
Palmer, E. P. and Guay, A. T. Reversible myopathy secondary to abuse of ipecac in patients with major eating disorders. N.Engl.J.Med. 12-5-1985;313(23):1457-1459.
Mofenson, H. C. and Caraccio, T. R. Benefits/risks of syrup of ipecac. Pediatrics 1986;77(4):551-552.
Tandberg, D., Diven, B. G., and McLeod, J. W. Ipecac-induced emesis versus gastric lavage: a controlled study in normal adults. Am.J.Emerg.Med. 1986;4(3):205-209.
Auerbach, P. S., Osterloh, J., Braun, O., Hu, P., Geehr, E. C., Kizer, K. W., and McKinney, H. Efficacy of gastric emptying: gastric lavage versus emesis induced with ipecac. Ann.Emerg.Med. 1986;15(6):692-698.
Schiff, R. J., Wurzel, C. L., Brunson, S. C., Kasloff, I., Nussbaum, M. P., and Frank, S. D. Death due to chronic syrup of ipecac use in a patient with bulimia. Pediatrics 1986;78(3):412-416.
Rosenberg, N. L. and Ringel, S. P. Myopathy from surreptitious ipecac ingestion. West J.Med. 1986;145(3):386-388.
Freedman, G. E., Pasternak, S., and Krenzelok, E. P. A clinical trial using syrup of ipecac and activated charcoal concurrently. Ann.Emerg.Med. 1987;16(2):164-166.
Friedman, A. G., Seime, R. J., Roberts, T., and Fremouw, W. J. Ipecac abuse: a serious complication in bulimia. Gen.Hosp.Psychiatry 1987;9(3):225-228.
Knight, K. M. and Doucet, H. J. Gastric rupture and death caused by ipecac syrup. South.Med.J. 1987;80(6):786-787.
Tenenbein, M., Cohen, S., and Sitar, D. S. Efficacy of ipecac-induced emesis, orogastric lavage, and activated charcoal for acute drug overdose. Ann.Emerg.Med. 1987;16(8):838-841.
Halbig, L., Gutmann, L., Goebel, H. H., Brick, J. F., and Schochet, S. Ultrastructural pathology in emetine-induced myopathy. Acta Neuropathol. 1988;75(6):577-582.
Boxer, L., Anderson, F. P., and Rowe, D. S. Comparison of ipecac-induced emesis with gastric lavage in the treatment of acute salicylate ingestion. J.Pediatr. 1969;74(5):800-803.
MacLean, W. C., Jr. A comparison of ipecac syrup and apomorphine in the immediate treatment of ingestion of poisons. J.Pediatr. 1973;82(1):121-124.
Adler, A. G., Walinsky, P., Krall, R. A., and Cho, S. Y. Death resulting from ipecac syrup poisoning. JAMA 5-16-1980;243(19):1927-1928.
Brotman, M. C., Forbath, N., Garfinkel, P. E., and Humphrey, J. G. Myopathy due to ipecac syrup poisoning in a patient with anorexia nervosa. Can.Med.Assoc.J. 9-1-1981;125(5):453-454.
Bennett, H. S., Spiro, A. J., Pollack, M. A., and Zucker, P. Ipecac-induced myopathy simulating dermatomyositis. Neurology 1982;32(1):91-94.
Neuvonen, P. J., Vartiainen, M., and Tokola, O. Comparison of activated charcoal and ipecac syrup in prevention of drug absorption. Eur.J.Clin.Pharmacol. 1983;24(4):557-562.
Stewart, J. J. Effects of emetic and cathartic agents on the gastrointestinal tract and the treatment of toxic ingestion. J Toxicol.Clin Toxicol. 1983;20(3):199-253.
Curtis, R. A., Barone, J., and Giacona, N. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose. Arch.Intern.Med 1984;144(1):48-52.
Luczynska, C. M., Marshall, P. E., Scarisbrick, D. A., and Topping, M. D. Occupational allergy due to inhalation of ipecacuanha dust. Clin.Allergy 1984;14(2):169-175.
Friedman, E. J. Death from ipecac intoxication in a patient with anorexia nervosa. Am.J.Psychiatry 1984;141(5):702-703.
Timberlake, G. A. Ipecac as a cause of the Mallory-Weiss syndrome. South.Med.J. 1984;77(6):804-805.
Wolowodiuk, O. J., McMicken, D. B., and O'Brien, P. Pneumomediastinum and retropneumoperitoneum: an unusual complication of syrup-of-ipecac-induced emesis. Ann.Emerg.Med. 1984;13(12):1148-1151.
Klein-Schwartz, W., Gorman, R. L., Oderda, G. M., Wedin, G. P., and Saggar, D. Ipecac use in the elderly: the unanswered question. Ann.Emerg.Med. 1984;13(12):1152-1154.
Schofferman, J. A. A clinical comparison of syrup of ipecac and apomorphine use in adults. JACEP. 1976;5(1):22-25.
Pond, S. M., Lewis-Driver, D. J., Williams, G. M., Green, A. C., and Stevenson, N. W. Gastric emptying in acute overdose: a prospective randomised controlled trial. Med J Aust 10-2-1995;163(7):345-349.
Olsen, K. M., Ma, F. H., Ackerman, B. H., and Stull, R. E. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal. Pharmacotherapy 1993;13(3):229-232.
Bond, G. R., Requa, R. K., Krenzelok, E. P., Normann, S. A., Tendler, J. D., Morris, C. L., McCoy, D. J., Thompson, M. W., McCarthy, T., Roblez, J., and . Influence of time until emesis on the efficacy of decontamination using acetaminophen as a marker in a pediatric population. Ann.Emerg.Med 1993;22(9):1403-1407.
Young, W. F., Jr. and Bivins, H. G. Evaluation of gastric emptying using radionuclides: gastric lavage versus ipecac-induced emesis. Ann.Emerg.Med. 1993;22(9):1423-1427.
Phillips, S., Gomez, H., and Brent, J. Pediatric gastrointestinal decontamination in acute toxin ingestion. J Clin Pharmacol 1993;33(6):497-507.
Veltri, J. C. and Temple, A. R. Telephone management of poisonings using syrup of ipecac. Clin.Toxicol. 1976;9(3):407-417.
Thyagarajan, D., Day, B. J., Wodak, J., Gilligan, B., and Dennett, X. Emetine myopathy in a patient with an eating disorder. Med J Aust. 12-6-1993;159(11-12):757-760.
Schneider, D. J., Perez, A., Knilamus, T. E., Daniels, S. R., Bove, K. E., and Bonnell, H. Clinical and pathologic aspects of cardiomyopathy from ipecac administration in Munchausen's syndrome by proxy. Pediatrics 1996;97(6 Pt 1):902-906.
Lacomis, D. Case of the month. June 1996--anorexia nervosa. Brain Pathol. 1996;6(4):535-536.
Litovitz, T., Clancy, C., Korberly, B., Temple, A. R., and Mann, K. V. Surveillance of loperamide ingestions: an analysis of 216 poison center reports. J.Toxicol.Clin.Toxicol. 1997;35(1):11-19.
Andersen, J. M., Keljo, D. J., and Argyle, J. C. Secretory diarrhea caused by ipecac poisoning. J.Pediatr.Gastroenterol.Nutr. 1997;24(5):612-615.
Saincher, A., Sitar, D. S., and Tenenbein, M. Efficacy of ipecac during the first hour after drug ingestion in human volunteers. J.Toxicol.Clin.Toxicol. 1997;35(6):609-615.
Ho, P. C., Dweik, R., and Cohen, M. C. Rapidly reversible cardiomyopathy associated with chronic ipecac ingestion. Clin.Cardiol. 1998;21(10):780-783.
Avau B, Borra V, Vanhove AC, Vandekerckhove P, De Paepe P, De Buck E. First aid interventions by laypeople for acute oral poisoning. Cochrane Database Syst Rev. 2018;12(12):CD013230.
Rossi AAB, de Oliveira LO, Venturini BA, dos Santos Silva R. Genetic diversity and geographic differentiation of disjunct Atlantic and Amazonian populations of Psychotria ipecacuanha (Rubiaceae). Genetica. 2009;136(1):57-67.
You Might Also Like
Select a condition to view a list of vitamins
CONDITIONS OF USE AND IMPORTANT INFORMATION: This information is meant to supplement, not replace advice from your doctor or healthcare provider and is not meant to cover all possible uses, precautions, interactions or adverse effects. This information may not fit your specific health circumstances. Never delay or disregard seeking professional medical advice from your doctor or other qualified health care provider because of something you have read on WebMD. You should always speak with your doctor or health care professional before you start, stop, or change any prescribed part of your health care plan or treatment and to determine what course of therapy is right for you.
This copyrighted material is licensed from Therapeutic Research Center, LLC. Information from this source is evidence-based and objective, and without commercial influence. For professional medical information on natural medicines, see Natural Medicines Comprehensive Database Professional Version.
Licensed from Therapeutic Research Center, LLC
Copyright © 1995-2025 by Therapeutic Research Center, LLC. All Rights Reserved.